Various therapeutic approaches toward killing glioma cells by inducing apoptosis have been developed, but these approaches are often hampered by anti-apoptotic mechanisms. In this study, we attempted to develop a technique that overrides the resistance toward apoptosis in glioma cells. To date, p53-and Fas-mediated apoptotic pathways have been shown to be different. Therefore, we carried out a gene therapy that combines the pro-apoptotic effect of these two different pathways. The recombinant adenoviruses (Advs) for p53 and Fas ligand (FL) (Adv-p53 and Adv-FL, respectively) were constructed. Transfecting the p53 gene into glioma cell lines (A-172 and U251 glioma cells) led to overexpression of Bax, a protein that induces permeability transition; at the same time, this transfection brought about an overexpression of Fas. To intensify Fas-mediated apoptosis, we transferred the FL gene together Regardless of whether a cell line is resistant or sensitive to FL-and p53-mediated apoptosis, coinfection with Adv-p53 and Adv-FL dramatically enhanced the degree of apoptosis of glioma cells. Our results indicate that the coinfection approach can be used as a modality for the gene therapy of gliomas, overriding the apoptosis-resistant mechanisms in glioma cells. Cancer Gene Therapy (2000) 7, 732-738
T ransfection of the wild-type (wt) p53 gene has been shown to induce apoptosis of various cancers in in vitro and in vivo animal experiments (reviewed in Ref. 1) as well as in a clinical study. 2 Roth et al 2 reported that in six of nine patients with lung cancer, tumor regression or growth stabilization occurred through retrovirus-mediated transfer of the p53 gene without vector-related toxic effects. Some cancers, however, are refractory to p53 gene therapy. 2 Although the specific mechanism that underlies p53-dependent apoptosis is unknown, p53 activates the transcription of Bax, which is a gene related to mitochondrial function. 3 Apoptosis is induced by collapse of the membrane potential of the mitochondria, which leads to loss of selective ion permeability (mitochondrial permeability transition (MPT)). 4 The mitochondrial damage is followed by activation of caspases, possibly by the release of cytochrome c 5, 6 and apoptogenic proteases 7 from the mitochondria, and results in apoptotic cell death. p53 induces the expression of Fas receptor, 8 but p53-mediated apoptosis occurs normally in Fas-defective mutant mice, 9 indicating that p53 and Fas apoptotic pathways are different. Because some cancers evade apoptotic cell death due to abnormality of pro-apoptotic genes involved in either MPT or Fasmediated apoptosis, 10 -13 simultaneous signal transduction in the p53-and Fas-mediated pathways could possibly lead to an effective cytopathic effect for cancers by overriding the anti-apoptotic mechanism of cancers that blocks the signal transduction in either the MPT-or Fas-mediated pathway. Combined induction of the Fas ligand (FL) gene and the p53 gene may render p53-resistant cancers sensitive to the p53 gene therapy. In this study, by using adenovirus (Adv)-mediated gene transduction, we have demonstrated that combined induction of FL with p53 drastically enhanced apoptosis in gliomas.
MATERIALS AND METHODS

Cell lines
The A-172 human glioma line was obtained from the American Type Culture Collection (Manassas, Va). The U251 human glioma line was obtained from the Tumor Registry of the Division of Cancer Treatment, National Cancer Institute (Frederick, Md). A-172 and U251 cells were maintained in Dulbecco's modified Eagle's medium (Nissui Pharmaceutical, Tokyo, Japan) containing 10% fetal bovine sera, 0.2% sodium bicarbonate, 2 mM glutamine, 100 U/mL penicillin, and 100 g/mL streptomycin.
Adenoviral vectors for FL and p53
Human FL cDNA (kindly provided by Dr. Mita, Osaka, Japan) was inserted into the SwaI site of pAxCALNLw 14 to generate pAxCALNL-hFL. The recombinant Adv for AxCALNL-hFL was generated using the method described previously. 15 The on/off switching unit CALNL-hFL consisted of the chicken ␤-actin (CA) promoter, 16 the neo gene, a poly(A) sequence flanked by a pair of loxP sites, the FL gene, and another poly(A) signal.
14 CALNL-hFL without NCre expresses the neo gene but does not express the FL gene. In the presence of NCre, which contains the Cre recombinase coding region, 14 the neo gene between the loxP sites is excised; the CA promoter and FL gene are joined together, resulting in the Adv expressing the FL gene under the control of the CA promoter.
14 Infection with AxCALNL-hFL (Adv-FL) was always accompanied by the Adv for NCre 14 (Adv-Cre) at a multiplicity of infection (MOI) that was half (50%) that of Adv-FL.
To increase the transduction efficiency of the p53 gene, we used an Adv vector with an F/K20 mutant fiber knob, AxCAhp53-F/K20. 17 This Adv for p53 (Adv-p53) is efficient for the transduction of genes into glioma cell lines. 17 Adv-mediated gene transduction was performed as described previously. 18 The total MOI was adjusted to be the same in all experimental groups by supplementation with the appropriate amount of the Adv for lacZ (Adv-lacZ).
Assessment of cell death
The frequency of hypodiploid cells was determined by propidium iodide staining of ethanol-permeabilized cells. Data were analyzed with CellQuest software on a FACScan (Becton Dickinson, San Jose, Calif) as described previously. 19 The DNA fluorescence gate was set up to exclude cell aggregates and debris. The percentage of cells that had undergone apoptosis was determined to be the percentage of the area of fluorescence smaller than the G 0 /G 1 peak, out of the total area of fluorescence. Each experiment was repeated at least three times. Adv-lacZ was used to adjust and maintain the constant total MOI of Adv used in each experiment. Statistical analysis was performed using analysis of variance (ANOVA) followed by Fisher's exact test; P Ͻ .01 was considered to be statistically significant.
Detection of Fas and FL
For flow cytometric (fluorescence-activated cell sorter (FACS)) analysis of Fas, 1 ϫ 10 6 cells were incubated for 20 minutes with 0.25 g of fluorescein isothiocyanate-conjugated mouse anti-human CD95 antibody (Ab) (33454X; PharMingen, San Diego, Calif). The data were analyzed with a FACScan. An isotype-matched control Ab was used for negative control staining.
For FACS analysis of FL, 10 6 cells were first incubated for 20 minutes with 5 L of biotinylated mouse anti-human FL Ab (SE-50082X; Sumimoto Electric, Yokohama, Japan), which recognizes the extracellular domain of FL; next, cells were incubated for 20 minutes with 0.5 g of streptavidin-phycoerythrin conjugate (13025D; PharMingen). The data were analyzed with a FACScan.
Immunoblot analysis
Proteins were extracted 48 hours after cells were infected with Adv. Immunoblot analysis was performed using the enhanced chemiluminescence kit (Amersham, Little Chalfont, UK) as described previously. 15 The primary Abs used were antihuman p53 mouse monoclonal Ab (OP09; Oncogene Science, Cambridge, Mass), mouse anti-human Bax monoclonal Ab (M010-3; Medical and Biological Laboratories, Nagoya, Japan), and goat anti-human caspase-3 polyclonal Ab (sc-1226; Santa Cruz Biotechnology, Santa Cruz, Calif).
RESULTS
Expression of p53 and FL in glioma cells infected with
Adv-p53 and Adv-FL Transfection of Adv-p53 into A-172 cells as well as into U251 cells induces the expression of p53 (Fig 1a) ; transfection of Adv-FL into these two cell lines induces the expression of FL (Fig 1b) . The size of the bands of p53 in A-172 (Fig 1a, lanes 1 and 2) is almost the same as wt p53 (Fig 1a, lane 3) , whereas that in U251 (Fig 1a, lanes 4 and 5) is smaller than wt p53 (Fig 1a, lane 6 ). It has been reported that A-172 cells harbor heterozygous nonfunctional p53, whereas U251 cells carry a point mutation of codon 273 of the p53 gene. 20 
Up-regulation of Bax and Fas in glioma cells by infection with Adv-p53
We examined whether p53 induction activates the expression of other pro-apoptotic genes. It was found that as the MOI at which Adv-p53 was transfected was increased, a higher level of Fas was expressed on the surface of both the A-172 cells and the U251 cells (Fig  2a) . This finding suggests that p53 gene transfection increases the expression level of Fas. It has been reported that the degree of apoptosis induced by FL increased as the expression level of Fas increased. 21 Thus, transduction of FL concomitant with p53 would enhance Fas-mediated apoptosis due to the increased expression of Fas by p53 transduction. Conversely, induction of p53 markedly increased the expression of Bax in A-172 and U251 cells (Fig 2b) . Anti-Bax Ab recognizes the 21-kDa 22 as well as the 18-kDa protein, which reportedly plays a role in the regulation of apoptosis. 23 Our previous report shows that similar levels of overexpressed Bax induced profound cellular death in glioma cells. 24 Drastically enhanced apoptosis in glioma cells by coinfection with Adv-p53 and Adv-FL We evaluated the effect of coinfecting A-172 cells and U251 cells with Adv-p53 and Adv-FL. In our previous report, we infected A-172 and U251 cells with Adv-FL at various MOIs, and those cells underwent apoptosis in an MOI-dependent manner. 15 Therefore, we fixed the MOIs of Adv-FL for A-172 cells (MOI of 100) and U251 cells (MOI of 30), and both cells had a similar, relatively low level of apoptosis (Fig 3a, A-172 , 3 Ϯ 0.1%; U251, 18.1 Ϯ 0.3%). A-172 cells were infected with Adv-p53 at MOIs of 30, 100, and 300. Other A-172 cells were coinfected with each of the same MOIs of Adv-p53 and with Adv-FL at an MOI of 100. Similarly, U251 cells were infected with Adv-p53 at MOIs of 10, 30, and 100). Other U251 cells were coinfected with each of the same MOIs of Adv-p53 and with Adv-FL at an MOI of 30. The frequency of hypodiploid cells in A-172 cells coinfected with Adv-p53 (at an MOI of 30, 100, or 300) and Adv-FL (at an MOI of 100) was significantly higher than that seen for cells infected with Adv-p53 alone (at an MOI of 30, 100, or 300) or Adv-FL alone (at an MOI of 100) (ANOVA, P Ͻ .001) at respective MOIs, as shown in Figure 3a . Similarly, the frequency of hypodiploid cells in U251 cells coinfected with Adv-p53 (at an MOI of 10, 30, or 100) and Adv-FL (at an MOI of 30) was significantly higher than that seen for cells infected with Adv-p53 alone (at an MOI of 10, 30, or 100) or Adv-FL alone (at an MOI of 30) (ANOVA, P Ͻ .001) at respective MOIs, as shown in Figure 3a . Thus, the apoptosis induced by coinfection with Adv-p53 and Adv-FL was significantly higher than that induced with Adv-p53 alone or Adv-FL alone in glioma cells. A-172 cells are relatively resistant to p53-mediated apoptosis (Fig 3, a and b, I , 2) and FL-mediated apoptosis (Fig 3,  a and b, I, 3) . 15 However, U251 cells are relatively sensitive to p53-mediated apoptosis (Fig 3, a and b, II, 2 ) and FL-mediated apoptosis (Fig 3, a and b, II, 3 ). 15 Regardless of whether a cell line is resistant (A-172) or sensitive (U251) to FL-and p53-mediated apoptosis, coinfection with Adv-p53 and Adv-FL induced a highly enhanced level of apoptosis (Fig 3a) .
DISCUSSION
A-172 cells are relatively resistant to the apoptosis induced by infection with Adv-p53 and Adv-FL, whereas U251 cells are highly susceptible to the apoptosis induced by infection with both Advs. This difference is due to the lower transduction efficiency of A-172 cells for Adv infection compared with that of U251 cells (Fig 1, a  and b) . Also, A-172 cells express a higher level of the anti-apoptotic Bcl-X L protein 25 than do U251 cells, 24 suggesting that high expression of Bcl-X L protein protected A-172 cells from apoptosis by transduction of p53 and FL. There are several advantages to coinfecting glioma cells with Advs of two pro-apoptotic genes, each having a different apoptotic pathway. First, expression of both p53 and FL may overcome the apoptotic-resistant mechanisms in glioma cells. Bcl-2, 26 Bcl-X L , 25 Fas-associated phosphatase-1, 27 and Fas-associated death domain-like interleukin-1-converting enzyme inhibitory protein 28 have been reported to protect cancer cells from apoptosis. Alternatively, one of the two pro-apoptotic pathways could be blocked due to a mutation in a pro-apoptotic gene such as p53, 10 Bax, 11 Fas, 12 and Fas-associated death domain-like interleukin-1-converting enzyme. 13 Thus, even if one pro-apoptotic pathway is blocked, expression of the second pro-apoptotic gene would bypass the resistance and kill the tumor via a different pro-apoptotic pathway.
Second, the combined transduction of p53 and FL into A-172 and U251 cells induces a highly intensified apoptotic effect. As shown in our study (Fig 3) , (Fig 3a) . Naumann et al 29 reported that retroviral Bax gene transfer did not sensitize malignant glioma cells to FL-induced apoptosis.
There are several possibilities to account for the controversial results. One possibility is that our adenoviral vectors used in this study induced much higher copy numbers of transduced genes compared with those of retroviral vectors, resulting in a higher level of Bax expression. Another possibility is that the elevated surface Fas expression by the p53 overexpression 8 further Adv for herpes simplex thymidine kinase gene, Trask et al 31 reported that the in vivo transduction efficiency of Adv was low in gliomas. In our preliminary in vivo experiments, Adv-FL showed a marked in vivo bystander effect, suggesting that Adv-FL would be beneficial with regard to induction of a strong in vivo cytotoxic effect despite low transduction efficiency. We experienced technical difficulty when we attempted to obtain the fiber-mutant p53 Adv (Adv-p53) with a high enough titer for in vivo experiments, owing to its severe cytotoxicity to the host 293 cells. The p53 gene product, which was highly expressed in glioma cells via the highly efficient Adv with F/K20 fiber mutant, 17, 32 caused severe premature apoptotic cell death of the 293 cells, resulting in a rather low-level titer of Adv viral production. Some technical improvements are necessary to obtain fiber-mutant Adv-p53 vectors with high titer to induce highly enhanced cytotoxicity in tumor masses in vivo. One possible approach is to develop and use apoptosis-resistant host cells for Adv production. 32 Clearly, further studies including in vivo therapeutic models are required to elucidate the efficacy and safety of this approach.
Third, because the combined transduction of the p53 and FL genes induces a synergistic apoptotic effect on glioma cells, the dosage of Adv of each of the two pro-apoptotic genes administered to patients can be decreased so as to reduce the opportunities for both the appearance of replication-competent Adv and the undesirable immune response related to Adv overdosage. Moreover, administering lower doses of Adv to patients could reduce the potential damage incurred in normal tissues. For example, in p53 gene therapy of gliomas, transfer of p53 to neighboring neurons should be reduced to the greatest extent possible, because Jordan et al 33 demonstrated that p53 gene transduction into cultured neurons induces apoptosis. However, neurons do not express Fas 34 and do express a low level of caspase-3 (CPP32), a pro-apoptotic molecule downstream of FL. 35 Therefore, neurons are resistant to FL-mediated cell death. 36 Cotransduction of p53, at a level lower than that used in our study, and FL, at a moderate level, would lead to remarkable apoptosis of glioma cells, without damaging neurons.
Fourth, gene therapy involving coinfection with p53 and FL would increase the effectiveness of conventional therapies. It has been shown that the degree of apoptosis of cancer cells is enhanced by the combination of chemotherapy and induction of p53 37 as well as by the combination of chemotherapy and induction of FL. 38 Induction of p53 sensitizes cancer cells to radiotherapy. 39 Radiotherapy up-regulates Fas in human p53 wt cancer cells. 40 Therefore, combined induction of p53 and FL is a good candidate for enhancing the therapeutic effect of chemotherapy as well as radiotherapy.
In conclusion, coinfection with Adv-p53 and Adv-FL dramatically enhanced the degree of apoptosis of glioma cells. This therapy is a practical and promising approach for the treatment of gliomas.
